title: The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasma.
abstract: OBJECTIVE
  Mutations involved in neoplastic progression may be able to serve as markers for the presence of small numbers of neoplastic cells that would otherwise escape detection in diagnostic assays. Previous retrospective studies have suggested that the sensitivity of the cytologic diagnosis of pancreatic and biliary tract carcinomas is improved when analysis includes Ki-ras exon 1, which is commonly mutated in these neoplasms. We report our experience with the systematic prospective application of Ki-ras gene analysis to the evaluation of fine-needle aspirates and brushings from the pancreatobiliary tract.
  
  
  METHODS
  Between September 1996 and April 1999, 75 pancreatic fine-needle aspirates and common bile duct brushings submitted for routine cytologic diagnosis were also evaluated for mutations in Ki-ras exon 1 by polymerase chain reaction/single-strand conformation polymorphism analysis. After routine preparation of the specimens, residual material was used for molecular analysis. Results are compared with the morphologic diagnosis and available clinical information.
  
  
  RESULTS
  Single-strand conformation polymorphism mutation patterns in Ki-ras were detected in 22 of the 70 consecutive clinical specimens with adequate DNA and at least 6 months of available clinical follow-up. Sensitivity, specificity, and positive predictive value for the presence of concurrent or subsequent pancreatobiliary carcinoma were 33%, 97%, and 93%, respectively, for definitive cytologic diagnosis alone, and 53%, 97%, and 95% for positive Ki-ras single-strand conformation polymorphism mutation pattern alone. If definitive positive cytology or atypical/suspicious cytology with a positive Ki-ras single-strand conformation polymorphism mutation pattern is used, sensitivity is 55%, specificity is 97%, and positive predictive value is 96% for the presence of pancreatobiliary carcinoma.
  
  
  CONCLUSIONS
  Results support the routine use of Ki-ras mutational analysis to increase the sensitivity of the cytologic evaluation of pancreatobiliary fine-needle aspirates and common bile duct brushings with atypical or suspicious morphology without compromising specificity.
authors.affiliation: Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520-8023, USA.
authors.forename: D A
authors.initials: DA
authors.lastname: Dillon
authors.forename: C C
authors.initials: CC
authors.lastname: Johnson
authors.forename: M D
authors.initials: MD
authors.lastname: Topazian
authors.forename: G
authors.initials: G
authors.lastname: Tallini
authors.forename: D L
authors.initials: DL
authors.lastname: Rimm
authors.forename: J C
authors.initials: JC
authors.lastname: Costa
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis / Q000235:genetics / Q000378:metabolism; D001650:Bile Duct Neoplasms / Q000175:diagnosis* / Q000235:genetics* / Q000378:metabolism; D003062:Codon; D004252:DNA Mutational Analysis; D005091:Exons; D011905:Genes, ras / Q000235:genetics*; D006801:Humans; D009154:Mutation; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000235:genetics* / Q000378:metabolism; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic; D018807:Polymorphism, Single-Stranded Conformational; D016283:Proto-Oncogene Proteins p21(ras) / Q000096:biosynthesis; D012680:Sensitivity and Specificity; D013997:Time Factors
chemical_list: D003062:Codon; C501009:HRAS protein, human; D016283:Proto-Oncogene Proteins p21(ras)